Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,417 hedge funds and large institutions have $76.7B invested in Celgene Corp in 2017 Q1 according to their latest regulatory filings, with 127 funds opening new positions, 563 increasing their positions, 544 reducing their positions, and 70 closing their positions.
81% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 70
11% more call options, than puts
Call options by funds: $1.23B | Put options by funds: $1.11B
10% more funds holding in top 10
Funds holding in top 10: 117 → 129 (+12)
8% more capital invested
Capital invested by funds: $71B → $76.7B (+$5.74B)
3% more funds holding
Funds holding: 1,375 → 1,417 (+42)
3% more repeat investments, than reductions
Existing positions increased: 563 | Existing positions reduced: 544
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.17B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$247M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$237M |
| 4 |
Ninety One (UK)
London,
United Kingdom
|
+$187M |
| 5 |
O
OppenheimerFunds
New York
|
+$178M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$625M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$341M |
| 3 |
Jennison Associates
New York
|
-$275M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$190M |
| 5 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$183M |
CELG Hedge Fund Activity: Q1 2017 in Review
1,417 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q1 2017, worth a combined $76.7B — up 8.1% from $71B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new CELG positions and 70 closed out — a net gain of 57 holders — while 563 added to existing stakes and 544 trimmed.
The largest buyer was BlackRock, adding an estimated $6.17B. The largest seller was Fidelity Investments, cutting an estimated $625M.
- 1,417 institutional investors held Celgene Corp (CELG) as of Q1 2017, up from 1,375 in Q4 2016.
- Funds reported $76.7B of Celgene Corp stock for Q1 2017, up 8.1% quarter-over-quarter.
- 127 funds opened new Celgene Corp positions in Q1 2017 and 70 closed out, a net change of +57 holders.
- The largest Celgene Corp buyer in Q1 2017 was BlackRock, an estimated $6.17B added.
- The largest Celgene Corp seller in Q1 2017 was Fidelity Investments, an estimated $625M sold.
Based on aggregated 13F filings for Q1 2017.